Acumen Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ABOS on Nasdaq
Location
427 Park St., Charlottesville, VA

Insiders trading volume in the past year

Acumen Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $45.3M Jun 10, 2024
Sands Capital Ventures Discovery Fund III, L.P. 10%+ Owner $11.9M Jul 6, 2021
Paul B. Manning 10%+ Owner $2.28M Jul 6, 2021
Robert D. Hardie 10%+ Owner $2.28M Jul 6, 2021
Daniel Joseph OConnell Chief Executive Officer, Director $1.06M -$108K -9.22% Jan 21, 2025
Matt Zuga CFO & Chief Business Officer $398K -$81K -16.9% Jan 21, 2025
Eric Siemers Chief Medical Officer $271K -$25.2K -8.5% Jan 21, 2025
Derek Meisner Chief Legal Officer & Corp Sec $256K -$25.9K -9.19% Jan 21, 2025
Russell Barton Chief Operating Officer $219K -$18.9K -7.95% Jan 21, 2025
James J. Doherty President and CDO $115K Jan 6, 2025
Amy Schacterle Chief Regulatory Officer $16.2K Jan 6, 2025
Laura Stoppel Director Jun 10, 2024
Jeffrey L. Ives Director Jun 10, 2024
Nathan B. Fountain Director Jun 10, 2024
Derrell Porter Director Jun 10, 2024
Kimberlee C. Drapkin Director Jun 10, 2024
Jeffrey Sevigny Director Jun 15, 2022
John A. Stalfort III Director Jun 10, 2024

Recent Insider Transactions by Companies or Individuals for Acumen Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.